Diverticulitis Disease Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Diverticulitis Disease Market Valuation Change Between Now And 2029?
The market size for the disease diverticulitis has substantially expanded in the past few years. This market will escalate from a value of $1.85 billion in 2024 to approximately $2.02 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.3%. The previous growth period’s boost can be traced back to factors such as the aging populace, changing eating patterns, rising obesity levels, and improvements in medical imaging.
Anticipated robust expansion is on the horizon for the diverticulitis disease market in the impending years, with projections stating it will reach a value of $2.91 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. This upward trend during the forecast period can be credited to factors such as the increased use of colonoscopy and endoscopy, raising awareness, the implementation of minimally invasive procedures, and the rise of personalized medicine. The period is also expected to witness major trends like preventive measures, advancement in diagnostic tools, models of collaborative care, and alterations in healthcare policies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp
What Underlying Factors Are Supporting The Diverticulitis Disease Market Growth?
The escalating trend of smoking addiction is anticipated to spur the expansion of the diverticulitis disease market. The increasing addiction to smoking is fueled by factors such as assertive promotion, societal acceptance, stress, and the addictive properties of nicotine. The rise in smoking rates can also be attributed to the availability of vape devices and e-cigarettes as well as peer pressure and societal influences, particularly among younger demographics. Smoking happens to bolster the diverticulitis treatment market as it heightens the risk of developing diverticular disease, which can impede blood flow to the colon and result in more serious complications. This subsequently creates a greater need for diagnostic and therapeutic solutions. For example, the production of cigarettes in July 2022 increased by 5.8% compared to June 2021, as per data from Statistics Canada, a Canadian government agency. In addition, the total sales of cigarettes saw a rise of 1.3% from May 2022, hitting 1.4 billion in June 2022. Hence, it can be concluded that the escalating trend of smoking addiction will stimulate the expansion of the diverticulitis disease market.
Which Sub-Segments Are Driving Growth Within The Diverticulitis Disease Market?
The diverticulitis diseasemarket covered in this report is segmented –
1) By Type: Uncomplicated; Complicated
2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test
3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids
4) By End-User: Specialty Centers; Hospitals; Research centers
Subsegments:
1) By Uncomplicated: Outpatient Treatment; Dietary Management; Antibiotic Therapy
2) By Complicated: Hospitalization; Surgical Intervention; Intravenous Antibiotics; Abscess Drainage
What Current And Upcoming Trends Are Shaping The Diverticulitis Disease Market?
Leading businesses in the diverticulitis disease market are striving to maintain their market stance by innovating and obtaining approval for novel drugs. The goal of these developments is to generate more efficient diverticulitis treatments, minimize potential complications, and enhance patient results. For instance, in April 2023, Seres’ microbiota medication for recurrent intestinal infections received approval from the United States Food and Drug Administration, a US federal entity. This innovative drug is curated to combat recurring gut infections and prevent the return of Clostridioides difficile (C. diff.) infections in adults 18 years and older. The green light for Vowst was given after a clinical trial enrolling 346 patients with recurring CDI showed a significant drop in infection recurrence among patients who received Vowst compared to those given a placebo. The orally administered drug comprises microbiota with Firmicutes spores, recognized for fostering a resilient microbiome that can efficiently prevent C. diff colonization.
Which Companies Hold A Competitive Edge In The 571 Market?
Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report
Which Region Dominates The Diverticulitis Disease Market Today?
North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp
Browse Through More Reports Similar to the Global Diverticulitis Disease Market 2025, By The Business Research Company
Inflammatory Bowel Disease Treatment Global Market Report 2025
Irritable Bowel Syndrome Ibs Treatment Global Market Report 2025
Gastric Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
